Dr. M-J Milloy, PhD, is a Research Scientist with the BC Centre on Substance Use (BCCSU) and Assistant Professor in the Division of AIDS, Department of Medicine at the University of British Columbia (UBC). Dr. Milloy is an infectious disease epidemiologist whose research focuses on the interrelationships between illicit drugs and HIV/AIDS—including HIV treatment patterns among people who use illicit drugs (PWUD) and adherence to HIV treatment among incarcerated PWUD—as well as the effects of cannabis on people living with HIV/AIDS or addiction.
Dr. Milloy is the Principal Investigator of the AIDS Care Cohort to Evaluate Exposure to Survival Services (ACCESS), an ongoing prospective cohort study funded by the US National Institutes of Health. ACCESS currently follows approximately 1,000 individuals living with HIV/AIDS who use illicit drugs.
During his nine years with the BCCSU, Dr. Milloy has authored more than 80 articles on topics that include the impacts of homelessness and incarceration on HIV treatment outcomes; patterns of non-fatal and fatal overdose; and the impact of Insite, North America’s first medically supervised injecting facility. Dr. Milloy has won several awards of merit, including the 2011 Bisby Fellowship from the Canadian Institutes of Health Research. Most recently, National Green BioMed, Ltd., a medical cannabis firm, committed a $1-million gift to UBC to study the therapeutic effects of cannabis and its potential to treat HIV.